Your browser doesn't support javascript.
loading
Attributable Burden and Expenditure of Cardiovascular Diseases and Associated Risk Factors in Mexico and other Selected Mega-Countries.
Mendoza-Herrera, Kenny; Pedroza-Tobías, Andrea; Hernández-Alcaraz, César; Ávila-Burgos, Leticia; Aguilar-Salinas, Carlos A; Barquera, Simón.
Afiliação
  • Mendoza-Herrera K; Center for Nutrition and Health Research, National Institute of Public Health, Cuernavaca, Morelos 62100, Mexico. cinys26@insp.mx.
  • Pedroza-Tobías A; Institute for Global Health Sciences, University of California, San Francisco, CA 94158, USA. Andrea.Pedroza-Tobias@ucsf.edu.
  • Hernández-Alcaraz C; Center for Nutrition and Health Research, National Institute of Public Health, Cuernavaca, Morelos 62100, Mexico. cesar.hernandez@insp.mx.
  • Ávila-Burgos L; Center for Health Systems Research, National Institute of Public Health, Cuernavaca, Morelos 62100, Mexico. leticia.avila@insp.mx.
  • Aguilar-Salinas CA; Unidad de Investigación de Enfermedades Metabolicas, Mexico City 14080, Mexico. caguilarsalinas@yahoo.com.
  • Barquera S; Departamento de Endocrinología y Metabolismo, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubiran, Mexico City 14080, Mexico. caguilarsalinas@yahoo.com.
Article em En | MEDLINE | ID: mdl-31652519
BACKGROUND: This paper describes the health and economic burden of cardiovascular diseases (CVD) in Mexico and other mega-countries through a review of literature and datasets. METHODS: Mega-countries with a low (Nigeria), middle (India), high (China/Brazil/Mexico), and very high (the U.S.A./Japan) human development index were included. The review was focused on prevalence of dyslipidemias and CVD economic impact and conducted according to the PRISMA statement. Public datasets of CVD indicators were explored. RESULTS: Heterogeneity in economic data and limited information on dyslipidemias were found. Hypertriglyceridemia and hypercholesterolemia were higher in Mexico compared with other countries. Higher contribution of dietary risk factors for cardiovascular mortality and greater probability of dying prematurely from CVD were observed in developing countries. From 1990-2016, a greater decrease in cardiovascular mortality in developed countries was registered. In 2015, a CVD expense equivalent to 4% of total health expenditure was reported in Mexico. CVD ranked first in health expenditures in almost all these nations and the economic burden will remain significant for decades to come. CONCLUSIONS: Resources should be assured to optimize CVD risk monitoring. Educational and medical models must be improved to enhance CVD diagnosis and the prescription and adherence to treatments. Long-term benefits could be attained by modifying the food system.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Efeitos Psicossociais da Doença Tipo de estudo: Etiology_studies / Health_economic_evaluation / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Humans País/Região como assunto: Africa / America do sul / Asia / Brasil / Mexico Idioma: En Revista: Int J Environ Res Public Health Ano de publicação: 2019 Tipo de documento: Article País de afiliação: México País de publicação: Suíça

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Efeitos Psicossociais da Doença Tipo de estudo: Etiology_studies / Health_economic_evaluation / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Humans País/Região como assunto: Africa / America do sul / Asia / Brasil / Mexico Idioma: En Revista: Int J Environ Res Public Health Ano de publicação: 2019 Tipo de documento: Article País de afiliação: México País de publicação: Suíça